MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Diabetes Treatment and Management
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,896 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,896 works in the cohort · of 4,299,418page 25 of 78

Labels cover 11 of 3,896 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,896 of 3,896 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 ( <scp>DPP</scp> ‐4) inhibitor omarigliptin or the once‐daily <scp>DPP</scp> ‐4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
Ronald Goldenberg, Ira Gantz, Paula J. Andryuk, Edward A. O’Neill, Keith D. Kaufman, Eseng Lai +3 more
2017· article· en· Diabetes Obesity and Metabolism· Medicine
machine prediction:candidate · noneconsensus · none
30
citations
affunlabeled
The cardiovascular effects of novel weight loss therapies
Muhammad Usman, Melanie J. Davies, Michael E. Hall, Subodh Verma, Stefan D. Anker, Julio Rosenstock +1 more
2023· article· en· European Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
30
citations
fundvenueno affno abstractunlabeled
Remission of Type 2 Diabetes
Dylan MacKay, Catherine B. Chan, Kaberi Dasgupta, Cliff Dominy, Michel Gagner, Susie Jin +12 more
2022· article· en· Canadian Journal of Diabetes· Medicine
machine prediction:candidate · noneconsensus · none
29
citations

How this was built: Screen · Findings · About